Wolverine Trading
BNTX icon

Wolverine Trading’s BioNTech BNTX Stock Holding History

Wolverine Trading’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$4.55M Buy
46,400
+1,800
+4% +$192K ﹤0.01% 1461
2025
Q2 		$4.76M Buy
44,600
+3,100
+7% +$313K ﹤0.01% 1089
2025
Q1 		$3.94M Sell
41,500
-23,100
-36% -$2.59M ﹤0.01% 1119
2024
Q4 		$7.27M Sell
64,600
-14,800
-19% -$1.69M 0.01% 966
2024
Q3 		$9.39M Buy
79,400
+16,300
+26% +$1.5M 0.01% 731
2024
Q2 		$5.07M Buy
63,100
+15,800
+33% +$1.44M 0.01% 984
2024
Q1 		$4.36M Sell
47,300
-4,800
-9% -$460K ﹤0.01% 1093
2023
Q4 		$5.5M Buy
52,100
+13,800
+36% +$1.39M 0.01% 1033
2023
Q3 		$4.16M Sell
38,300
-14,200
-27% -$1.57M ﹤0.01% 1107
2023
Q2 		$5.62M Buy
+52,500
New +$5.9M 0.01% 845
2023
Q1 		– Sell
-51,000
Closed -$7.66M – 4243
2022
Q4 		$7.66M Sell
51,000
-3,500
-6% -$539K 0.01% 705
2022
Q3 		$7.28M Buy
54,500
+7,600
+16% +$1.16M 0.01% 685
2022
Q2 		$6.66M Sell
46,900
-24,300
-34% -$3.71M 0.01% 686
2022
Q1 		$12.4M Sell
71,200
-173,400
-71% -$29.1M 0.02% 599
2021
Q4 		$62.8M Sell
244,600
-3,400
-1% -$931K 0.07% 177
2021
Q3 		$68.8M Buy
248,000
+104,500
+73% +$33.2M 0.08% 165
2021
Q2 		$32.7M Buy
143,500
+70,600
+97% +$13.3M 0.05% 268
2021
Q1 		$7.61M Buy
72,900
+24,500
+51% +$2.6M 0.01% 851
2020
Q4 		$4.06M Buy
+48,400
New +$4.75M 0.01% 1212

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wolverine Trading's BNTX Position: Q3 2025 in Review

Wolverine Trading increased its BioNTech (BNTX) stake by 43% in Q3 2025, buying an estimated $398K and bringing the position to 12,434 shares worth $1.22M. The position accounts for ﹤0.01% of the portfolio, ranked #2693.

Wolverine Trading first reported a position in BNTX in Q4 2020 and has held it in 16 quarters since. The position peaked at $5.09M in Q2 2021. 254 funds tracked by Wall St. Rank hold BNTX as of Q3 2025.

  • Wolverine Trading held 12,434 shares of BioNTech worth $1.22M as of Q3 2025.
  • Wolverine Trading bought 3,726 BioNTech shares in Q3 2025, an estimated $398K.
  • BioNTech made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #2693 holding.
  • Wolverine Trading first reported a position in BioNTech in Q4 2020 and has held it in 16 quarters since.
  • Wolverine Trading's BioNTech position peaked at $5.09M in Q2 2021.
  • 254 funds tracked by Wall St. Rank held BioNTech as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.